HAP VAP Clinical Trials: Can we reduce complexity to reduce cost while improving the quality of the data and inference we make? FDA Approves Zerbaxa for HAP, VAP Respiratory Therapy Novelties in the treatment of community acquired and hospital acquired pneumonia Novelties in the treatment of community acquire Ventilator Associated Pneumonia (VAP) EMCrit Project The prevalence, presentation and outcome of colistin susceptible only Acinetobacter Baumannii associated pneumonia in intensive care unit: a multicenter observational study Scientific Reports